Multi-strain probiotics obtained from the human gut have shown promising effects in reducing irritable bowel syndrome (IBS) disease severity, and should be further studied as a potential treatment for the condition, say Korean researchers.
Consuming a prebiotic agave fructan jelly could reduce visceral hypersensitivity with short-chain fatty acids, attenuate anxiety and modulate brain activity in irritable bowel syndrome patients with constipation, according to a recent study. The findings...
A new proprietary method to deliver the Indian botanical extract Boswellia, could boost bioavailability and help manage the symptoms of irritable bowel syndrome (IBS), finds a study by Italian botanical player Indena.
A brain-to-gut pathway, where neurological symptoms begin first, may explain why higher levels of anxiety and depression are predictors of developing gastrointestinal disorders, a study has determined.
Lesaffre Human Care, the northern France-headquartered manufacturer of bacteria-based health ingredients, has received health claims approval from the Canadian Health Authorities (CHA) for its product Ibsium, which helps to relieve the symptoms associated...
Dispatches from the International Yakult Symposium
Doctors are now showing interest in Symprove’s non-dairy multi-strain probiotic for irritable bowel syndrome (IBS) treatment, but it took a published medical paper to get their attention, says the company chairman.
Dispatches from the IPA World Congress in Athens, Greece
Consumption of a probiotic containing functional food product has no clinical benefits for people with irritable bowel syndrome (IBS) when compared to a placebo treatment, according to new clinical trial data.
Research backing the gastrointestinal potential of a multi-strain probiotic-fibre product is being presented at United European Gastroenterology Congress in Amsterdam today – a rare speaking opportunity at a medical-focused event with 12,000 attendees.
Swedish probiotics supplier Probi has announced an alliance with an unnamed “major multinational” food company that will assist it in its quest to win the first probiotic health claim in the European Union.
UK firm Probiotics International (Protexin) has acquired fellow UK digestive products maker, The Healthy Bowels Company, in an undisclosed deal that sees Protexin gain control of €2m+ pre-probiotic combination brand, Lepicol.
French Canadian company Institut Rosell has agreed a seven-year partnership with Swedish probiotic research and the development firm Probi covering dietary supplements based on its bacterial Lp299v strain.
The UK Advertising Standards Authority (ASA) has ruled against press adverts promoting the bowel health potential of probiotic and fibre-containing food supplements due to a lack of scientific backing.
Probiotics should be considered as living drugs rather than “simple good bacteria” in order to become effective treatment options for IBS, according to Joseph Haddad, medical director of Institut Rosell-Lallemand.
Most Australian consumers are still not ready to believe the claims made by probiotic products, despite a steady and growing interest in their value for improving digestive health, according to Datamonitor.
Increasing knowledge of how the gut and brain is opening up the possibilities for probiotics. At the 5th International Yakult Symposium in Amsterdam, Stephen Daniells met Professor John Bienenstock from McMaster University to find out where the current...
Finnish dairy and ingredients supplier, Valio, will submit data it believes may alter the negative opinion for a probiotic-related, gastro-intestinal health claim delivered by the European Food Safety Authority (EFSA) recently.
Institut Rosell-Lallemand has teamed up with Ranbaxy and Aristo
Pharmaceuticals to distribute supplements based on a probiotic
bacteria, which will see it become available in the massive Indian
market for Irritable Bowel Syndrome.
Dietary supplements based on the Lactobacillus plantarum
299v probiotic by Institut Rosell-Lallemand have expanded
further into Europe - a move which shows the increasing popularity
of the friendly bacteria.
A unique technique to extract fucoidans from sea weed through a
coldwater extraction process has been trademarked by Marinova,
allowing the company to protect its processing capability and gain
further leverage in the nutraceutical...
Marinova's new fucoidan facility in Hobart, Tasmania, is on
schedule to commence operations from next month, offering fucoidans
from a broader range of microalgae species for nutraceutical and
Institut Rosell has obtained more evidence that its Lacidofil
probiotic, composed of two strains of live lactic acid bacteria,
may help alleviate the symptoms of irritable bowel syndrome (IBS),
when used in conjunction with conventional...